FDA says OSI drug effective against lung cancer
The Associated Press
WASHINGTON — Federal health regulators say OSI Pharmaceutical's Tarceva slows the progression of lung cancer and extends patients' lives when used as a …
FDA to consider wider use of TarcevaNewsday (subscription)
FDA Panel To Consider Wider Use Of Tarceva In Lung CancerWall Street Journal
Osi Pharmaceuticals Cancer Drug Tarceva Faces Panel For Expanded UsePortfolio.com (blog)
Reuters
all 131 news articles »

FDA says OSI drug effective against lung cancer – The Associated Press

Share and Enjoy:
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks

Random Posts

Related posts:

  1. Genentech wants lung cancer drug expanded – San Francisco Business Times
  2. Eli Lilly Says Lung Cancer Drug Shows Benefit (LLY)
  3. Drug stocks chase broader market south – MarketWatch